⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

BioXcel Therapeutics, Inc. Common Stock

$0.8089
+0.0072 (+0.90%)

Volume:

1.076M ($882.43K)

Market Capitalization:

$24.98M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

BioXcel Therapeutics Market Segments

Overnight

*No Trades in Segment

Premarket

-0.0674(-7.51%)
Open$0.8974
Close$0.8300
Low$0.7900
Low Change-0.1074 (-11.97%)
High$0.9560
High Change+0.0586 (+6.53%)
Range$0.1660
Volume547.757K
Dollar Volume$454.64K

After Hours Yesterday

+0.0121(+1.52%)
Open$0.7985
Close$0.8106
Low$0.7985
Low Change0.0000 (0.00%)
High$0.8106
High Change+0.0121 (+1.52%)
Range$0.0121
Volume29.135K
Dollar Volume$23.62K

Regular Trading Hours Yesterday

-0.0383(-4.56%)
Open$0.8400
Close$0.8017
Low$0.7979
Low Change-0.0421 (-5.01%)
High$0.8400
High Change+0.0000 (+0.00%)
Range$0.0421
Volume670.002K
Dollar Volume$537.14K

Premarket Yesterday

-0.0413(-4.73%)
Open$0.8724
Close$0.8311
Low$0.8200
Low Change-0.0524 (-6.01%)
High$0.8887
High Change+0.0163 (+1.87%)
Range$0.0687
Volume196.896K
Dollar Volume$163.64K

BioXcel Therapeutics News

There is no current news for this stock at the moment.

BioXcel Therapeutics Top Trades

BioXcel Therapeutics's top trade so far today returned +8.73%, while the top short trade returned -17.14%.

BioXcel Therapeutics Moving Averages

5 Day Moving Average (SMA5)$0.9003
10 Day Moving Average (SMA10)$0.9436
20 Day Moving Average (SMA20)$0.8894
50 Day Moving Average (SMA50)$1.0126
100 Day Moving Average (SMA100)$1.0859
200 Day Moving Average (SMA200)$1.4162

BioXcel Therapeutics Statistics

Average Volume (30 Days)967.8K
P/E Ratio (Current)-.37
EPS (Current)-$2.26
Dividend Yield0.00%
Free Cash Flow-$50.90M
Cash Ratio0.09
Current Ratio0.21
Quick Ratio0.21
Debt to Equity-0.90
Enterprise Value$117.59M
EV to EBITDA-2.64
EV to Sales158.48
Price to Book-0.23
Price to Cash Flow
Price to Free Cash Flow
Price to Sales35.02
Return on Assets-2.46%
Return on Equity0.61%

BioXcel Therapeutics Stock Splits

There has been 1 stock split for BioXcel Therapeutics (BTAI). The reverse stock split occured on February 10, 2025 and reduced the outstanding shares at a ratio of 16:1.

DateTypeRatio
Feb 10, 2025Reverse16:1

BioXcel Therapeutics Dividends

There have been no dividends for BioXcel Therapeutics (BTAI).